TJP3
Basic information
Region (hg38): 19:3708362-3750813
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TJP3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 1 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 0 | 6 | 1 |
Variants in TJP3
This is a list of pathogenic ClinVar variants found in the TJP3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-3728675-T-C | Likely benign (Jun 01, 2022) | |||
19-3730507-C-T | Benign (Aug 26, 2017) | |||
19-3730627-C-T | Likely benign (Sep 01, 2022) | |||
19-3739003-C-T | Likely benign (Jul 01, 2022) | |||
19-3740705-C-T | Likely benign (Dec 01, 2022) | |||
19-3746850-C-T | Likely benign (Sep 01, 2022) | |||
19-3747877-C-T | Likely benign (Sep 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TJP3 | protein_coding | protein_coding | ENST00000589378 | 21 | 42705 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.71e-23 | 0.0214 | 125543 | 0 | 205 | 125748 | 0.000815 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.670 | 686 | 638 | 1.07 | 0.0000465 | 5930 |
Missense in Polyphen | 258 | 255.31 | 1.0105 | 2417 | ||
Synonymous | 0.0487 | 269 | 270 | 0.996 | 0.0000204 | 1929 |
Loss of Function | 1.12 | 39 | 47.3 | 0.825 | 0.00000276 | 474 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00143 | 0.00140 |
Ashkenazi Jewish | 0.000496 | 0.000496 |
East Asian | 0.00370 | 0.00365 |
Finnish | 0.00128 | 0.00125 |
European (Non-Finnish) | 0.000448 | 0.000431 |
Middle Eastern | 0.00370 | 0.00365 |
South Asian | 0.000594 | 0.000588 |
Other | 0.00131 | 0.00130 |
dbNSFP
Source:
- Function
- FUNCTION: TJP1, TJP2, and TJP3 are closely related scaffolding proteins that link tight junction (TJ) transmembrane proteins such as claudins, junctional adhesion molecules, and occludin to the actin cytoskeleton (PubMed:16129888). The tight junction acts to limit movement of substances through the paracellular space and as a boundary between the compositionally distinct apical and basolateral plasma membrane domains of epithelial and endothelial cells. Binds and recruits PATJ to tight junctions where it connects and stabilizes apical and lateral components of tight junctions (PubMed:16129888). Promotes cell-cycle progression through the sequestration of cyclin D1 (CCND1) at tight junctions during mitosis which prevents CCND1 degradation during M-phase and enables S-phase transition (PubMed:21411630). With TJP1 and TJP2, participates to the junctional retention and stability of the transcription factor DBPA, but is not involved in its shuttling to the nucleus (By similarity). Contrary to TJP2, TJP3 is dispensable for individual viability, embryonic development, epithelial differentiation, and the establishment of TJs, at least in the laboratory environment (By similarity). {ECO:0000250|UniProtKB:O62683, ECO:0000250|UniProtKB:Q9QXY1, ECO:0000269|PubMed:16129888, ECO:0000269|PubMed:21411630}.;
- Pathway
- Tight junction - Homo sapiens (human)
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 0.13
- rvis_percentile_EVS
- 63.49
Haploinsufficiency Scores
- pHI
- 0.134
- hipred
- N
- hipred_score
- 0.275
- ghis
- 0.426
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.671
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tjp3
- Phenotype
- normal phenotype;
Zebrafish Information Network
- Gene name
- tjp3
- Affected structure
- post-vent region
- Phenotype tag
- abnormal
- Phenotype quality
- increased curvature
Gene ontology
- Biological process
- Cellular component
- nucleus;plasma membrane;bicellular tight junction
- Molecular function
- protein binding